{
}
Sanofi is in exclusive negotiations to sell a majority stake in its consumer healthcare subsidiary Opella, which produces Doliprane, to the American investment fund CD & R for over 15 billion euros. This move raises concerns about potential relocation of production, despite government efforts to reduce drug import dependence. French officials are urging commitments to maintain Opella's operations in France amid fears of losing the iconic Doliprane brand.
Sanofi is negotiating to sell a 50% stake in its consumer healthcare division, Opella, to U.S. private equity firm CD&R for approximately 15.5 billion euros. The French government is closely monitoring the deal, emphasizing the need for economic commitments to maintain operations and decision-making in France.
Legal & General Investment Management offers two significant ETFs, L&G Healthcare Breakthrough and L&G Pharma Breakthrough, targeting growth in the healthcare and pharmaceutical sectors. These medium-high risk products can enhance diversified portfolios, especially in light of ongoing interest in medical research post-Covid-19. The iShares Healthcare Innovation UCITS ETF stands out on the Italian stock exchange, reflecting strong performance and a focus on healthcare innovation.
The new Minister of Health faces critical challenges, including chronic overcrowding in emergency departments, a widening healthcare deficit projected at €11.4 billion by 2024, and ongoing medical desertification. Promises of reforms, such as task delegation to healthcare professionals and direct access to specialists, remain unfulfilled amid rising healthcare costs and political turmoil. Additionally, contentious issues like the Aide Médicale d'Etat scheme and a stalled bill on assisted dying complicate the landscape for healthcare reform in France.
Sanofi
Companies
| Symbol | SNY |
| Name | Sanofi |
| Currency | USD |
| Sector | Health Care |
| IndustryGroup | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Pharmaceuticals |
| Market | NASDAQ Global Select |
| Country | France |
| State | |
| City | Paris |
| Zipcode | 75008 |
| Website | http://www.sanofi.com |
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Sanofi in talks to sell Doliprane brand to American investment fund
11:57 11.10.2024
Sanofi in talks to sell 50 percent stake in Opella to CD&R
Euro
Les Echos A.C
Le Monde 3D Sàrl
Clayton Dubilier & Rice (CD&R)
Sanofi
PAI Partners SAS
FRA
USA
Marc Ferracci
Antoine Armand
Show more
09:00 11.10.2024
investing in healthcare and pharmaceutical etfs for long term growth opportunities
AstraZeneca PLC
Novartis AG
Sanofi
CHE
USA
GBR
BlackRock
Legal & General Investment Management
Show more
09:00 01.10.2024
challenges facing new health minister amid rising costs and access issues
09:00 22.09.2024
Trending
Subcategory
Corporate News
Industry Trends
Global Trade Developments
Stock Market Updates
Cryptocurrency Trends
Startups & Entrepreneurship
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Supply Chain Management
Central Banks and Digital Currencies
Government Economic Policies
CEO Changes
Workplace Trends
Blockchain Infrastructure Development
Crypto Policies and Governance
Banking Regulations
Central Bank Actions
Finance Mergers & Acquisitions
Venture Capital Investments
Retail and Consumer Goods
Countries:
Companies:
Apple Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Tesla, Inc.
MARA Holdings, Inc.
Cleanspark Inc
Citigroup Inc.
Vodafone Idea Limited
JM Financial Limited
Fuse Science, Inc.
Arla Foods A.M.B.A.
Currencies:
People: